- Title
- Combining Iclepertin (BI 425809) With Computerized Cognitive Training in Patients With Schizophrenia: Baseline Data From an Ongoing Phase II Trial
- Creators
- Sean McDonald - Boehringer Ingelheim (Canada) Ltd, Burlington, ON, CanadaEric Fu - Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USAGlen Wunderlich - Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USAPhilip D. Harvey - University of Miami
- Publication Details
- CNS spectrums, Vol.28(2), pp.230-230
- Publisher
- Cambridge University Press
- Number of pages
- 1
- Grant note
- Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH (NCT03859973/1346-0038)
- Academic Unit
- Miller School of Medicine; UMMG Dept of Psychiatry & Behavioral Sciences
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031787487202976
Journal article
Combining Iclepertin (BI 425809) With Computerized Cognitive Training in Patients With Schizophrenia: Baseline Data From an Ongoing Phase II Trial
CNS spectrums, Vol.28(2), pp.230-230
2023-04
Metrics
12 Record Views